Reduced cerebellar cortical thickness in World Trade Center responders with cognitive impairment.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
16 03 2022
Historique:
received: 28 09 2021
accepted: 24 02 2022
revised: 21 02 2022
entrez: 17 3 2022
pubmed: 18 3 2022
medline: 5 4 2022
Statut: epublish

Résumé

Prior research has demonstrated high levels of cognitive and physical functional impairments in World Trade Center (WTC) responders. A follow-up neuroimaging study identified changes to white matter connectivity within the cerebellum in responders with cognitive impairment (CI). In the first study to examine cerebellar cortical thickness in WTC responders with CI, we fielded a structural magnetic resonance imaging protocol. WTC responders (N = 99) participated in a structural magnetic resonance imaging (MRI) study, of whom 48 had CI. Participants with CI did not differ demographically or by intracranial volume when compared to cognitively unimpaired participants. MRIs were processed using the CERES imaging pipeline; bilateral cortical thickness in 12 cerebellar lobules was reported. Analyses were completed comparing mean cerebellar cortical thickness across groups. Lobules were examined to determine the location and functional correlates of reduced cerebellar cortical thickness. Multivariable-adjusted analyses accounted for the false discovery rate. Mean cerebellar cortical thickness was reduced by 0.17 mm in responders with CI. Decrements in cerebellar cortical thickness were symmetric and located in the Cerebellar Crus (I and II), and in Lobules IV, VI, VIIb, VIIIa, VIIIb, and IX. Cerebellar cortical thickness was associated with episodic memory, response speed, and tandem balance. WTC responders with CI had evidence of reduced cerebellar cortical thickness that was present across lobules in a pattern unique to this cohort.

Identifiants

pubmed: 35296637
doi: 10.1038/s41398-022-01873-6
pii: 10.1038/s41398-022-01873-6
pmc: PMC8927406
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

107

Subventions

Organisme : NIA NIH HHS
ID : R01 AG049953
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG067590
Pays : United States
Organisme : NIOSH CDC HHS
ID : U01 OH011314
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG066514
Pays : United States

Informations de copyright

© 2022. The Author(s).

Références

Gordon N. The cerebellum and cognition. Eur J Paediatr Neurol. 2007;11(4):232–4.
pubmed: 17400009 doi: 10.1016/j.ejpn.2007.02.003
Schmahmann JD, Sherman JC. The cerebellar cognitive affective syndrome. Brain. 1998;121(Pt 4):561–79.
pubmed: 9577385 doi: 10.1093/brain/121.4.561
Schmahmann JD, Weilburg JB, Sherman JC. The neuropsychiatry of the cerebellum—insights from the clinic. Cerebellum. 2007;6:254–67.
pubmed: 17786822 doi: 10.1080/14734220701490995
Keren‐Happuch E, Chen SHA, Ho MHR, Desmond JE. A meta‐analysis of cerebellar contributions to higher cognition from PET and fMRI studies. Hum brain Mapp. 2014;35:593.
doi: 10.1002/hbm.22194
Ashida R, Cerminara NL, Edwards RJ, Apps R, Brooks JC. Sensorimotor, language, and working memory representation within the human cerebellum. Hum brain Mapp. 2019;40:4732–47.
pubmed: 31361075 pmcid: 6865458 doi: 10.1002/hbm.24733
Clouston S, Brewster P, Kuh D, Richards M, Cooper R, Hardy R, et al. The dynamic relationship between physical function and cognition in longitudinal aging cohorts. Epidemiol Rev. 2013;35:33–50.
pubmed: 23349427 pmcid: 3578448 doi: 10.1093/epirev/mxs004
Gellersen HM, Guo CC, O’Callaghan C, Tan RH, Sami S, Hornberger M. Cerebellar atrophy in neurodegeneration—a meta-analysis. J Neurol Neurosurg Psychiatry. 2017;88:780.
pubmed: 28501823 doi: 10.1136/jnnp-2017-315607
Daniels RD, Clouston SAP, Hall CB, Anderson KR, Bennett DA, Bromet EJ, et al. A workshop on cognitive aging and impairment in the 9/11-exposed population. Int J Environ Res Public Health. 2021;18:681–705.
pmcid: 7830144 doi: 10.3390/ijerph18020681
Chen A, Clouston SAP, Kritikos M, Richmond L, Meliker J, Mann F, et al. A deep learning approach for monitoring parietal-dominant Alzheimer’s disease in World Trade Center responders at midlife. Brain Commun.
Mukherjee S, Clouston S, Kotov R, Bromet E, Luft B. Handgrip strength of World Trade Center (WTC) responders: the role of re-experiencing posttraumatic stress disorder (PTSD) symptoms. Int J Environ Res Public Health. 2019;16:1128.
pmcid: 6480128 doi: 10.3390/ijerph16071128
Clouston S, Guralnik JM, Kotov R, Bromet EJ, Luft BJ. Functional limitations among responders to the World Trade Center attacks 14 years after the disaster: implications of chronic posttraumatic stress disorder. J Trauma Stress. 2017;30:443–52.
pubmed: 29024005 pmcid: 5679479 doi: 10.1002/jts.22219
Diminich ED, Clouston SAP, Kranidis A, Kritikos M, Kotov R, Kuan P, et al. Chronic posttraumatic stress disorder and comorbid cognitive and physical impairments in World Trade Center responders. J Trauma Stress. 2020;34:616–627.
pubmed: 33219599 pmcid: 8137717 doi: 10.1002/jts.22631
Clouston SAP, Kritikos M, Deri Y, Horton M, Pellecchia AC, Santiago-Michels S, et al. A cortical thinning signature to identify World Trade Center responders with possible dementia. Intelligence Based Med. 2021:100032.
Deri Y, Clouston S, DeLorenzo C, Gardus JD III, Horton M, Tang C, et al. Selective hippocampal subfield volume reductions in World Trade Center responders with cognitive impairment. Alzheimer’s Dement. 2021;13:e12165.
Kritikos M, Clouston SAP, Diminich ED, Deri Y, Yang X, Carr M, et al. Pathway analysis for plasma beta-amyloid, Tau and neurofilament light (ATN) in World Trade Center responders at midlife. Neurol Ther. 2020;9:159–71.
pubmed: 32350803 pmcid: 7229074 doi: 10.1007/s40120-020-00189-1
Clouston SAP, Hall CB, Kritikos M, Bennett DA, DeKosky S, Edwards J, et al. Cognitive impairment and World Trade Centre-related exposures. Nat Rev Neurol. 2022;18:103–116.
pubmed: 34795448 doi: 10.1038/s41582-021-00576-8
Huang C, Kritikos M, Clouston SA, Deri Y, Serrano-Sosa M, Bangiyev L, et al. White matter connectivity in incident mild cognitive impairment: a diffusion spectrum imaging study of World Trade Center responders at midlife. J Alzheimer’s Dis. 2021;80:1209–1219.
doi: 10.3233/JAD-201237
Clouston SAP, Deri Y, Horton M, Tang C, Diminich E, DeLorenzo C, et al. Reduced cortical thickness in World Trade Center responders with cognitive impairment. Alzheimers Dement (Amst). 2020;12:e12059.
Romero JE, Coupé P, Giraud R, Ta V-T, Fonov V, Park MTM, et al. CERES: a new cerebellum lobule segmentation method. Neuroimage. 2017;147:916–24.
pubmed: 27833012 doi: 10.1016/j.neuroimage.2016.11.003
Sörös P, Wölk L, Bantel C, Bräuer A, Klawonn F, Witt K. Replicability, repeatability, and long-term reproducibility of cerebellar morphometry. Cerebellum. 2021;20:439–453.
pubmed: 33421018 pmcid: 8213608 doi: 10.1007/s12311-020-01227-2
Sullivan EV, Zahr NM, Saranathan M, Pohl KM, Pfefferbaum A. Convergence of three parcellation approaches demonstrating cerebellar lobule volume deficits in alcohol use disorder. NeuroImage Clin. 2019;24:101974.
pubmed: 31419768 pmcid: 6704050 doi: 10.1016/j.nicl.2019.101974
McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dement. 2011;7:263–9.
doi: 10.1016/j.jalz.2011.03.005
Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatrics Soc. 2005;53:695–9.
doi: 10.1111/j.1532-5415.2005.53221.x
Maruff P, Thomas E, Cysique L, Brew B, Collie A, Snyder P, et al. Validity of the CogState brief battery: relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and AIDS dementia complex. Arch Clin Neuropsychol. 2009;24:165–78.
pubmed: 19395350 doi: 10.1093/arclin/acp010
Lim YY, Pietrzak RH, Bourgeat P, Ames D, Ellis KA, Rembach A, et al. Relationships between performance on the Cogstate Brief Battery, neurodegeneration, and Aβ accumulation in cognitively normal older adults and adults with MCI. Arch Clin Neuropsychol. 2015;30:49–58.
pubmed: 25467942 doi: 10.1093/arclin/acu068
Hammers D, Spurgeon E, Ryan K, Persad C, Heidebrink J, Barbas N, et al. Reliability of repeated cognitive assessment of dementia using a brief computerized battery. Am J Alzheimer’s Dis Other Dement®. 2011;26:326–33.
doi: 10.1177/1533317511411907
Racine AM, Clark LR, Berman SE, Koscik RL, Mueller KD, Norton D, et al. Associations between performance on an abbreviated CogState battery, other measures of cognitive function, and biomarkers in people at risk for Alzheimer’s disease. J Alzheimers Dis. 2016;54:1395–408.
pubmed: 27589532 pmcid: 5074904 doi: 10.3233/JAD-160528
Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49:M85–M94.
pubmed: 8126356 doi: 10.1093/geronj/49.2.M85
da Camara SM, Alvarado BE, Guralnik JM, Guerra RO, Maciel AC. Using the short Physical Performance Battery to screen for frailty in young-old adults with distinct socioeconomic conditions. Geriatr Gerontol Int. 2013;13:421–8.
pubmed: 22882512 doi: 10.1111/j.1447-0594.2012.00920.x
Clouston SAP, Diminich ED, Kotov R, Pietrzak RH, Richards M, Spiro A 3rd, et al. Incidence of mild cognitive impairment in World Trade Center responders: long-term consequences of re-experiencing the events on 9/11/2001. Alzheimers Dement (Amst). 2019;11:628–36.
doi: 10.1016/j.dadm.2019.07.006
Clouston S, Pietrzak RH, Kotov R, Richards M, Spiro A 3rd, Scott S, et al. Traumatic exposures, posttraumatic stress disorder, and cognitive functioning in World Trade Center responders. Alzheimers Dement. 2017;3:593–602.
doi: 10.1016/j.trci.2017.09.001
First MB, Spitzer RL, Gibbon M, Williams JB. Structured Clinical Interview for DSM-IV Axis I Disorders: Patient Edition (February 1996 Final), SCID-I/P. Biometrics Research Department, New York State Psychiatric Institute; 1998.
Schisterman EF, Cole SR, Platt RW. Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology. 2009;20:488.
pubmed: 19525685 pmcid: 2744485 doi: 10.1097/EDE.0b013e3181a819a1
Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B (Methodol). 1995;57:289–300.
Julkunen V, Niskanen E, Muehlboeck S, Pihlajamaki M, Kononen M, Hallikainen M, et al. Cortical thickness analysis to detect progressive mild cognitive impairment: a reference to Alzheimer’s disease. Dement Geriatr Cogn Disord. 2009;28:404–12.
pubmed: 19907176 doi: 10.1159/000256274
Zammit AR, Piccinin AM, Duggan EC, Koval AV, Clouston SAP, Robitaille A, et al. A coordinated multi-study analysis of the longitudinal association between handgrip strength and cognitive function in older adults. J Gerontol B Psychol Sci Soc Sci. 2021;76:229–41.
pubmed: 31187137 doi: 10.1093/geronb/gbz072
Schmahmann JD. The cerebellum and cognition. Neurosci Lett. 2019;688:62–75.
pubmed: 29997061 doi: 10.1016/j.neulet.2018.07.005
Liu LK, Chou KH, Hsu CH, Peng LN, Lee WJ, Chen WT, et al. Cerebellar-limbic neurocircuit is the novel biosignature of physio-cognitive decline syndrome. Aging (Albany NY). 2020;12:25319–36.
pmcid: 7803525 doi: 10.18632/aging.104135
Stoodley CJ, Valera EM, Schmahmann JD. Functional topography of the cerebellum for motor and cognitive tasks: An fMRI study. NeuroImage. 2012;59:1560–70.
pubmed: 21907811 doi: 10.1016/j.neuroimage.2011.08.065
Eckert MA, Keren NI, Roberts DR, Calhoun VD, Harris KC. Age-related changes in processing speed: unique contributions of cerebellar and prefrontal cortex. Front Hum Neurosci. 2010;4:10.
pubmed: 20300463 pmcid: 2839847
Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA Research Framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement. 2018;14:535–62.
pubmed: 29653606 pmcid: 5958625 doi: 10.1016/j.jalz.2018.02.018
Kritikos M, Clouston S, Diminich ED, Deri Y, Yang X, Carr M, et al. Pathway analysis for plasma β-amyloid, Tau and neurofilament light (ATN) in World Trade Center responders at midlife. Neurol Ther. 2020;9:159–171.
pubmed: 32350803 pmcid: 7229074 doi: 10.1007/s40120-020-00189-1
Clouston S, Deri Y, Horton M, Tang C, Diminich ED, Pellecchia A, et al. Reduced cortical thickness in World Trade Center responders with cognitive impairment: neuroimaging/differential diagnosis. Alzheimer’s Dement. 2020;16:e039996.
doi: 10.1002/alz.039996
Klunk WE, Koeppe RA, Price JC, Benzinger TL, Devous MD Sr, Jagust WJ, et al. The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET. Alzheimer’s Dement. 2015;11:1–15. e14.
doi: 10.1016/j.jalz.2014.07.003
Clouston S, Diminich ED, Kotov R, Pietrzak RH, Richards M, Spiro A III, et al. Incidence of mild cognitive impairment in World Trade Center responders: long-term consequences of re-experiencing the events on 9/11/2001. Alzheimer’s Dement. 2019;11:628–36.
Kuan P-F, Clouston S, Yang X, Kotov R, Bromet E, Luft BJ. Molecular linkage between post-traumatic stress disorder and cognitive impairment: a targeted proteomics study of World Trade Center responders. Transl Psychiatry. 2020;10:1–15.
doi: 10.1038/s41398-020-00958-4
Kuan PF, Clouston S, Yang X, Che C, Gandy S, Kotov R, et al. Single‐cell transcriptomics analysis of mild cognitive impairment in World Trade Center disaster responders. Alzheimer’s Dement 2021;13:e12154.
Deri Y, Clouston SA, DeLorenzo C, Gardus JD, Bartlett EA, Santiago-Michels S, et al. Neuroinflammation and mild cognitive impairment in World Trade Center responders at midlife: a pilot study using [18F]-FEPPA PET imaging. Brain Behav Immunity Health. 2021;16:100287
doi: 10.1016/j.bbih.2021.100287

Auteurs

Sean A P Clouston (SAP)

Department of Family, Population, and Preventive Medicine, Renaissance School of Medicine at Stony Brook, Stony Brook, NY, USA. sean.clouston@stonybrookmedicine.edu.
Program in Public Health, Renaissance School of Medicine at Stony Brook, Stony Brook, NY, USA. sean.clouston@stonybrookmedicine.edu.

Minos Kritikos (M)

Program in Public Health, Renaissance School of Medicine at Stony Brook, Stony Brook, NY, USA.

Chuan Huang (C)

Department of Radiology, Renaissance School of Medicine at Stony Brook, Stony Brook, NY, USA.

Pei-Fen Kuan (PF)

Department of Applied Mathematics, Stony Brook University, Stony Brook, NY, USA.

Paul Vaska (P)

Department of Radiology, Renaissance School of Medicine at Stony Brook, Stony Brook, NY, USA.
Department of Biomedical Engineering, Stony Brook University, Stony Brook, NY, USA.

Alison C Pellecchia (AC)

Department of Medicine, Renaissance School of Medicine at Stony Brook, Stony Brook, NY, USA.

Stephanie Santiago-Michels (S)

Department of Medicine, Renaissance School of Medicine at Stony Brook, Stony Brook, NY, USA.

Melissa A Carr (MA)

Department of Medicine, Renaissance School of Medicine at Stony Brook, Stony Brook, NY, USA.

Sam Gandy (S)

Center for Cognitive Health and NFL Neurological Care, Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Mount Sinai Alzheimer's Disease Research Center, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Mary Sano (M)

Mount Sinai Alzheimer's Disease Research Center, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Evelyn J Bromet (EJ)

Department of Psychiatry, Renaissance School of Medicine at Stony Brook, Stony Brook, NY, USA.

Roberto G Lucchini (RG)

Department of Environmental Health Sciences, Robert Stempel College of Public Health, Florida International University, Miami, FL, USA.

Benjamin J Luft (BJ)

Director of the World Trade Center Health and Wellness Program, Department of Medicine, Renaissance School of Medicine at Stony Brook, Stony Brook, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH